Benefit-risk assessment of telithromycin in the treatment of community-acquired pneumonia.
about
Benefit-risk assessment of telithromycin in the treatment of community-acquired pneumonia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Benefit-risk assessment of tel ...... community-acquired pneumonia.
@en
Benefit-risk assessment of tel ...... community-acquired pneumonia.
@nl
type
label
Benefit-risk assessment of tel ...... community-acquired pneumonia.
@en
Benefit-risk assessment of tel ...... community-acquired pneumonia.
@nl
prefLabel
Benefit-risk assessment of tel ...... community-acquired pneumonia.
@en
Benefit-risk assessment of tel ...... community-acquired pneumonia.
@nl
P2860
P1433
P1476
Benefit-risk assessment of tel ...... community-acquired pneumonia.
@en
P2093
Steven D Brown
P2860
P304
P356
10.2165/00002018-200831070-00002
P577
2008-01-01T00:00:00Z
P6179
1017431122